伴侣动物保健市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024年，全球伴侣动物保健市场规模达1,248亿美元，预计到2034年将以7.2%的复合年增长率成长，达到2,494亿美元。宠物日益人性化，以及人们对动物健康和保健意识的不断提升，导致对综合兽医解决方案的需求不断增长。如今，越来越多的宠物主人积极投资于预防性医疗保健、定期健康体检和寄生虫控制，从而推动了伴侣动物保健领域的支出成长。除了这些行为转变之外，全球宠物收养率的上升和可支配收入的提高也进一步刺激了对宠物医疗服务、产品和高级护理解决方案的需求。

兽医护理领域的数位转型也已成为关键的成长动力。随着远距医疗平台和远端监控工具的引入，宠物主人可以比以往更便捷地获得兽医专业知识。宠物保险的日益普及也使市场受益，这提高了宠物医疗的可负担性，并增加了获得必要治疗和预防保健服务的管道。随着宠物主人越来越多地寻求为其宠物提供专业和全面的医疗保健，该行业不断创新，推出健康产品和数位工具，以增强护理服务。这些进步不仅扩大了兽医服务的覆盖范围，也改善了不同动物物种的健康状况。

伴侣动物医疗保健涵盖了为家养动物（例如狗、猫、马等）设计的广泛的医疗服务和解决方案。该市场涵盖各种产品和服务，从药品、诊断到兽医服务。在这些细分市场中，兽医服务在2024年占据最大份额，价值890亿美元，预计到2034年将翻一番，达到1798亿美元。此细分市场提供广泛的服务，例如医疗、宠物寄养、美容、训练、保险服务和健康计划。伴侣动物慢性病盛行率的上升以及常规和预防性照护支出的增加，持续推动对这些服务的需求。

根据动物种类，市场可分为狗、猫、马和其他动物。 2024年，狗类市场占据全球市场份额的53.5%，领先全球市场。强劲表现得益于狗作为家庭伴侣的普及，这意味着在营养、常规体检、疫苗接种、美容和特殊治疗方面的支出增加。宠物主人也越来越关注特定品种的健康需求，并越来越多地选择量身定制的健康计划，这进一步增强了这一领域的需求。

从通路来看，伴侣动物保健市场细分为兽医院药局、零售药局和电商平台。兽医院药局在2024年占据了最大的市场份额，预计在预测期内将以6.6%的复合年增长率成长。这些药房通常设在兽医院和诊所内，方便患者在咨询后立即获得处方药和非处方药。由于靠近诊断和治疗中心，这些药房可以更快地配药并提供个人指导。此外，这些药房配备了专业的兽医药理学人员，提高了宠物治疗的安全性和精准度。随着处方药和复杂疗法的需求不断增长，这一细分市场的相关性和影响力也将持续扩大。

从区域来看，北美引领全球伴侣动物保健市场，2024年营收达544亿美元，预计2034年将达到918亿美元，复合年增长率为5.4%。该地区受益于完善的兽医基础设施、高度的宠物健康意识以及强大的保险生态系统。强大的诊所网路、日益增长的人工智慧诊断应用以及成熟的宠物护理市场进一步巩固了其领先地位。北美还拥有多家从事宠物药物、诊断和健康解决方案开发与分销的公司，这有助于其在全球市场中保持竞争优势。

伴侣动物保健市场竞争激烈，全球企业和专业供应商均力求提升自身影响力。产业参与者透过投资研发、数位技术和服务拓展，不断提升自身产品服务。合作伙伴关係、数位医疗创新以及对个人化宠物照护的关注等策略性倡议，将继续主导这一快速发展产业的竞争态势。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 宠物拥有率上升
    • 慢性病盛行率不断上升
    • 不断进步的技术
    • 扩大兽医服务线上平台
  • 产业陷阱与挑战
    • 治疗费用高昂
    • 发展中地区的准入受限
  • 市场机会
    • 扩大宠物保险覆盖范围
    • 个性化兽药需求不断成长
• 成长潜力分析
• 2024年宠物数量统计
• 报销场景
• 动物保健产业的创投场景
• 监管格局
• 未来市场趋势
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 关键进展
  • 併购
  • 伙伴关係和合作
  • 扩张计划

第五章：市场估计与预测：按产品，2021 - 2034 年

• 主要趋势
• 製药
  • 药物
    • 抗寄生虫药
    • 消炎剂
    • 抗感染药物
    • 皮质类固醇
    • 镇静剂
    • 心血管药物
    • 胃肠道药物
  • 疫苗
    • 减毒活疫苗（MLV）
    • 灭活疫苗
    • 重组疫苗
  • 药物饲料添加剂
    • 抗生素
    • 维生素
    • 胺基酸
    • 酵素
    • 抗氧化剂
    • 益生元和益生菌
    • 矿物质
    • 碳水化合物
    • 丙二醇
• 医疗器材
  • 兽医诊断设备
  • 兽医麻醉设备
  • 兽医病人监护设备
  • 兽医手术设备
  • 兽医耗材
  • 其他医疗器材
• 兽医服务
  • 美容服务
  • 寄宿及日托
  • 培训服务
  • 宠物保险
  • 医疗服务
  • 其他兽医服务

第六章：市场估计与预测：按动物，2021 - 2034 年

• 主要趋势
• 狗
• 猫
• 马匹
• 其他动物

第七章：市场估计与预测：按配销通路，2021 - 2034 年

• 主要趋势
• 兽医院药房
• 零售药局
• 电子商务

第八章：市场估计与预测：按地区，2021 - 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第九章：公司简介

• B Braun
• Boehringer Ingelheim
• Ceva
• Dechra
• Elanco
• Endovac
• Figo Pet Insurance
• Hartville
• Hester
• HIPRA
• Hollard
• IDEXX Laboratories
• Mars
• Medtronic
• Merck
• Neogen
• PetIQ
• Phibro
• Vetoquinol
• Virbac
• Zoetis

The Global Companion Animal Healthcare Market was valued at USD 124.8 billion in 2024 and is estimated to grow at a CAGR of 7.2% to reach USD 249.4 billion by 2034. The increasing humanization of pets, along with the growing awareness around animal health and wellness, has led to a rising demand for comprehensive veterinary solutions. More pet owners today are actively investing in preventive healthcare, regular wellness checkups, and parasite control, contributing to higher spending across the companion animal health sector. Alongside these behavioral shifts, rising global pet adoption rates and higher disposable incomes are further fueling the demand for medical services, products, and advanced care solutions for pets.

Digital transformation in veterinary care has also emerged as a key growth driver. With the introduction of telemedicine platforms and remote monitoring tools, pet owners can access veterinary expertise more conveniently than ever before. The market is also benefiting from the growing adoption of pet insurance, which improves affordability and access to necessary treatments and preventive care services. As pet owners increasingly seek specialized and holistic healthcare for their animals, the industry continues to innovate with wellness products and digital tools that enhance care delivery. These advancements are not only expanding the reach of veterinary services but also improving health outcomes across various animal species.

Companion animal healthcare encompasses a wide spectrum of medical services and solutions designed for domesticated animals such as dogs, cats, horses, and others. The market includes a variety of products and services, from pharmaceuticals and diagnostics to veterinary services. Among these segments, veterinary services held the largest share in 2024, valued at USD 89 billion, and are expected to double to USD 179.8 billion by 2034. This segment includes a broad range of offerings such as medical treatments, pet boarding, grooming, training, insurance services, and wellness programs. The rising prevalence of chronic conditions among companion animals and increasing expenditures on routine and preventive care continue to drive demand for these services.

Based on the type of animal, the market is divided into dogs, cats, horses, and others. The dogs segment led the global market in 2024, accounting for a 53.5% share. This strong performance is attributed to the high popularity of dogs as household companions, which translates into greater spending on nutrition, routine checkups, vaccinations, grooming, and specialized treatments. Pet owners are also becoming more aware of breed-specific health needs and are increasingly opting for tailored wellness plans, thereby further strengthening the demand within this segment.

In terms of distribution, the companion animal healthcare market is segmented into veterinary hospital pharmacies, retail pharmacies, and e-commerce platforms. Veterinary hospital pharmacies commanded the largest market share in 2024 and are projected to grow at a CAGR of 6.6% during the forecast period. These pharmacies are typically integrated within veterinary clinics and hospitals, providing immediate access to prescribed and over-the-counter medications after consultations. Their proximity to diagnostic and treatment services allows for faster medication dispensing and personalized guidance. Moreover, these pharmacies are staffed with professionals specialized in veterinary pharmacology, improving safety and precision in pet treatments. As the demand for prescription-based drugs and complex therapies grows, the relevance and influence of this segment continue to expand.

Regionally, North America led the global companion animal healthcare market with a revenue of USD 54.4 billion in 2024 and is projected to reach USD 91.8 billion by 2034, registering a CAGR of 5.4%. The region benefits from well-established veterinary infrastructure, high awareness around pet wellness, and a robust insurance ecosystem. A strong network of clinics, growing use of AI-driven diagnostics, and a mature pet care market further contribute to its leadership position. North America also houses several companies involved in the development and distribution of pet medications, diagnostics, and wellness solutions, which helps maintain a competitive edge in the global landscape.

The companion animal healthcare market is highly competitive, with a mix of global players and specialized providers aiming to strengthen their presence. Industry participants are continuously enhancing their offerings by investing in research, digital technologies, and service expansion. Strategic initiatives such as partnerships, innovation in digital health, and a focus on personalized pet care continue to define the competitive dynamics of this rapidly evolving sector.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Product
  • 2.2.3 Animal
  • 2.2.4 Distribution channel
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising pet ownership rate
    • 3.2.1.2 Increasing prevalence of chronic conditions
    • 3.2.1.3 Growing technological advancements
    • 3.2.1.4 Expanding online platforms for veterinary services
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of treatment
    • 3.2.2.2 Limited access in developing regions
  • 3.2.3 Market opportunities
    • 3.2.3.1 Expanding pet insurance coverage
    • 3.2.3.2 Growing demand for personalized veterinary medicines
• 3.3 Growth potential analysis
• 3.4 Pet population statistics 2024
• 3.5 Reimbursement scenario
• 3.6 Venture capitalist scenario in animal health industry
• 3.7 Regulatory landscape
• 3.8 Future market trends
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Pharmaceuticals
  • 5.2.1 Drugs
    • 5.2.1.1 Antiparasitic
    • 5.2.1.2 Anti-inflammatory
    • 5.2.1.3 Anti-infectives
    • 5.2.1.4 Corticosteroids
    • 5.2.1.5 Tranquilizers
    • 5.2.1.6 Cardiovascular drugs
    • 5.2.1.7 Gastrointestinal drugs
  • 5.2.2 Vaccines
    • 5.2.2.1 Modified live vaccines (MLV)
    • 5.2.2.2 Killed inactivated vaccines
    • 5.2.2.3 Recombinant vaccines
  • 5.2.3 Medicated feed additives
    • 5.2.3.1 Antibiotics
    • 5.2.3.2 Vitamins
    • 5.2.3.3 Amino acids
    • 5.2.3.4 Enzymes
    • 5.2.3.5 Antioxidants
    • 5.2.3.6 Prebiotics and probiotics
    • 5.2.3.7 Minerals
    • 5.2.3.8 Carbohydrates
    • 5.2.3.9 Propandiol
• 5.3 Medical devices
  • 5.3.1 Veterinary diagnostic equipment
  • 5.3.2 Veterinary anesthesia equipment
  • 5.3.3 Veterinary patient monitoring equipment
  • 5.3.4 Veterinary surgical equipment
  • 5.3.5 Veterinary consumables
  • 5.3.6 Other medical devices
• 5.4 Veterinary services
  • 5.4.1 Grooming services
  • 5.4.2 Boarding and daycare
  • 5.4.3 Training services
  • 5.4.4 Pet insurance
  • 5.4.5 Medical services
  • 5.4.6 Other veterinary services

Chapter 6 Market Estimates and Forecast, By Animal, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Dogs
• 6.3 Cats
• 6.4 Horses
• 6.5 Other animals

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Veterinary hospital pharmacy
• 7.3 Retail pharmacy
• 7.4 E-commerce

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 B Braun
• 9.2 Boehringer Ingelheim
• 9.3 Ceva
• 9.4 Dechra
• 9.5 Elanco
• 9.6 Endovac
• 9.7 Figo Pet Insurance
• 9.8 Hartville
• 9.9 Hester
• 9.10 HIPRA
• 9.11 Hollard
• 9.12 IDEXX Laboratories
• 9.13 Mars
• 9.14 Medtronic
• 9.15 Merck
• 9.16 Neogen
• 9.17 PetIQ
• 9.18 Phibro
• 9.19 Vetoquinol
• 9.20 Virbac
• 9.21 Zoetis